keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1].
説明 | LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1]. |
別名 | LCMV gp33-41 (TFA) |
分子量 | 1158.24 |
分子式 | C50H74N11F3015S |
CAS No. | TP1629 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LCMV gp33-41 (TFA) (151705-84-9 free base) TP1629 LCMV gp-33-41 (TFA) (151705-84-9 free base) 151705-84-9 LCMV gp3341 (TFA) (151705849 free base) 151705-84-9 free base LCMV gp33 41 (TFA) (151705 84 9 free base) LCMV gp33-41 (TFA) LCMV gp33-41 Inhibitor inhibitor inhibit